Scintimammography with Tc-99m Sestamibi

Acta Medica Austriaca

Volumn 24, Issue 2, 1997, Pages 46-49

  Khalkhali, I ^a   Iraniha, S ^a   Cutrone, J A ^a   Diggles, Linda E ^a   Klein, S R ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Breast imaging; Scintimammography; Technetium Sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST; BREAST DISEASE; BREAST TUMOR; CALCINOSIS; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROADENOMA; HUMAN; MIDDLE AGED; MULTICENTER STUDY; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030625320     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. American Cancer Society: Cancer facts and figures. Atlanta GA, American Cancer Society, 1942.
2. Wingo PA, Tong T, Bolden S: Cancer statistics 1995. CA Cancer J Clin 1995;45:8-30.
3. Sickles EA: Mammographic features of early breast cancer. AJR 1984;143: 461-464.
4. Moskowitz M: The predictive value of certain mammographic signs in screening for breast cancer. Cancer 1983;51:1007-1011.
5. Niloff PH, Sheiner NM: False negative mammograms in patients with breast cancer. Can J Surg 1981;24:50-52.
6. Pollei SR, Mettler FA, Barstow SA, Moradian G, Moskowita M: Occult breast cancer: Prevalence and radiographic detectability. Radiology 1987;163: 459-462.
7. Kopans DB: Positive predictive value of mammography. AJR 1992;158: 521-526.
8. O' Tuama LA, Packard AG, Treves ST: SPECT imaging of pediatric brain tumor with hexakis methoxyisobutyl isonitrile 99Tc. J Nucl Med 1990;31:2040-2041.
9. Caner B, Kitapel M, Unlu M, Erbengi G, Calikoglu T, Gogus T, Bekdik C: Tc 99m Sestamibi uptake in benign and malignant bone lesions: A comparative study with Tc 99m MDP. J Nucl Med 1992;33:319-324.
10. Balon HR, Fink-Bennett DM, Stoffer SS: Tc 99m Sestamibi uptake by recurrent Hurtle cell carcinoma of the thyroid. J Nucl Med 1992;33:1393-1395.
11. O' Driscoll CM, Baker F, Casey M, Duffy G: Localization of recurrent medullary throid carcinoma with Tc 99m methoxy isobutyl nitrile scintigraphy. A case report. J Nucl Med 1991;32:2281-2283.
12. Kitapci MT, Tastekin G, Turgut M, Caner B, Kars A, Barista I, Bekdik C: Preoperative localization of parathyroid carcinoma using Tc 99m MIBI. Clin Nucl Med 1993;18:217-219.
13. Taillifer R, Boucher Y Potrin C, Lambert R: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with Tc 99m Sestamibi (double phase study). J Nucl Med 1992;33:1801-1807.
14. Khalkhali I, Mena I, Jouanne E, Diggles L, Venegas R, Block J, Alle K, Klein S: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Col Surg 1994;178:491-197.
15. Iraniha S, Khalkhali I, Cutrone J, Diggles L, Klein K: Breast Cancer imaging: Can Tc 99m Sestamibi Scintimammography fit in? Medscape Women's Health 1997;2(4): in press.
16. Diggles L, Mena I, Khalkhali I: Technical aspects of prone dependent breast scintimammograph. J Nucl Med Technol 1994;22:165-170.
17. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Khalkhali S, Moss J, Klein S: Scintimammography: The complementary role of Tc 99m Sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
18. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S: Technetium 99m Sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
19. Bird RE, Wallace TW, Yankaskas BC: Analysis of cancers missed at the screening mammography. Radiology 1992;184:613-617.
20. Kopans DB: Breast cancer detection in an institution: Is mammography detrimental? Cancer 1993;72:1457-1460.
21. Muller ST, Guth-Tougelides B, Creuzig H: Imaging of malignant tumors with Tc 99m Sestamibi SPECT. Eur J Nucl Med 1987;28:562.
22. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones A, Holman B, Piwnica-Worms D: Subcellular distribution and analysis of Tc 99m Sestamibi in isolated perfused rat hearts. J Nucl Med 1992;33:1516-1521.
23. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A: In vitro uptake of Tc 99m Teboroxime in carcinoma cell lines and normal cell lines: Comparison with Tc 99m Sestamibi and thallium-201. J Nucl Med 1993;34: 1949-1952.
24. Gupta P, Waxman A, Nguyen K, Phillips E, Yadagar J, Silberman A, Memsic L: Correlation of Tc 99m Sestamibi uptake with histopathologic characteristics in patients with benign breast disease. J Nucl Med 1996; 37(Suppl.):250(P).
25. Khalkhali I, Villanueva-Meyer J, Edell SL, Hanelin L, Lugo C, Taillefer R, Freeman L, Neal C, Scheff A, Connolly J, Schnitt S, Baum J, Houlihan M, Hale C, Haber S: Diagnostic accuracy of Tc 99m Sestamibi breast imaging in breast cancer detection. J Nucl Med 1996;37(Suppl):74(P).
26. Jackson VP, Hendrick RE, Feig S, Kopans D: Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
27. Khalkhali I, Cutrone J, Mena I, Diggles L, Khalkhali S, Venegas R, Klein S: The usefulness of scintimammography in patients with dense breast on mammogram. J Nucl Med 1995;36:52(P).
28. Khalkhali I, Villanueva-Meyer J, Edell SL, Hanelin L, Lugo C, Taillefer R, Freeman L, Neal C, Scheff A, Connolly J, Schnitt S, Baum J, Houlihan M, Hale C, Haber S: Impact of breast density on the diagnostic accurary of Tc 99m Sestamibi breast imaging in the detection of breast cancer. J Nucl Med 1996;37(Suppl):74(P).
29. Helbich TH, Becherer A, Tratting S, Leitha T, Kelkar P, Seifert M, Gnant M, Staudenherz A, Rudas M, Wolf G, Mostbeck G: Differentiation of benign and malignant breast lesions MR imaging versus Tc 99m Sestamibi Scintimammography. Radiology 1997;202:421-429.
30. Taillifer R, Turpin S, Lambert R, Benjamin C, Gagnon A, Cantin J, Leveille J: Detection of axillary lymph node involvement with Tc 99m Sestamibi imaging in patients with primary breast cancer. J Nucl Med 1996;37(Suppl): 75(P).
31. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Klein S: Breast cancer staging using Tc 99m Sestamibi scintimammography. Clin Nucl Med 1995;20:858(P).
32. Mankoff DA, Gralow JR, Dunnwald LK, Drucker MJ, Ellis G, Livingston RB: Tc 99m Sestamibi scintimammography to measure the breast cancer response to neo-adjuvant chemotheraphy. Nucl Med 1996;37(Suppl):252(P).